Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients

J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1818-1827. doi: 10.1111/jdv.19996. Epub 2024 Apr 10.

Abstract

Background: Data on dermatological manifestations of Costello syndrome (CS) remain heterogeneous and lack in validated description.

Objectives: To describe the dermatological manifestations of CS; compare them with the literature findings; assess those discriminating CS from other RASopathies, including cardiofaciocutaneous syndrome (CFCS) and the main types of Noonan syndrome (NS); and test for dermatological phenotype-genotype correlations.

Methods: We performed a 10-year, large, prospective, multicentric, collaborative dermatological and genetic study.

Results: Thirty-one patients were enrolled. Hair abnormalities were ubiquitous, including wavy or curly hair and excessive eyebrows, respectively in 68% and 56%. Acral excessive skin (AES), papillomas and keratotic papules (PKP), acanthosis nigricans (AN), palmoplantar hyperkeratosis (PPHK) and 'cobblestone' papillomatous papules of the upper lip (CPPUL), were noted respectively in 84%, 61%, 65%, 55% and 32%. Excessive eyebrows, PKP, AN, CCPUL and AES best differentiated CS from CFCS and NS. Multiple melanocytic naevi (>50) may constitute a new marker of attenuated CS associated with intragenic duplication in HRAS. Oral acitretin may be highly beneficial for therapeutic management of PPHK. No significant dermatological phenotype-genotype correlation was determined between patients with and without HRAS c.34G>A (p.G12S).

Conclusions and relevance: This validated phenotypic characterization of a large number of patients with CS will allow future researchers to make a positive diagnosis, and to differentiate CS from CFCS and NS.

Publication types

  • Multicenter Study

MeSH terms

  • Acanthosis Nigricans / genetics
  • Acitretin / therapeutic use
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Costello Syndrome* / complications
  • Costello Syndrome* / genetics
  • Diagnosis, Differential
  • Ectodermal Dysplasia / genetics
  • Eyebrows / abnormalities
  • Eyebrows / pathology
  • Facies
  • Failure to Thrive / etiology
  • Failure to Thrive / genetics
  • Female
  • Heart Defects, Congenital / complications
  • Heart Defects, Congenital / genetics
  • Humans
  • Infant
  • Keratoderma, Palmoplantar / genetics
  • Keratolytic Agents / therapeutic use
  • Male
  • Noonan Syndrome / complications
  • Noonan Syndrome / genetics
  • Papilloma / genetics
  • Papilloma / pathology
  • Phenotype
  • Prospective Studies
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • Young Adult

Substances

  • Proto-Oncogene Proteins p21(ras)
  • HRAS protein, human
  • Acitretin
  • Keratolytic Agents

Supplementary concepts

  • Cardiofaciocutaneous syndrome